Skip to main content
SpringerLink
Log in

Ovarian Stimulation Prior to Elective Oocyte Cryopreservation

  • Chapter
  • First Online:
Preventing Age Related Fertility Loss

  • 704 Accesses

Abstract

The demand of fertility preservation with no urgent medical indication or for social reasons has increased in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Birch Petersen K, et al. Family intentions and personal considerations on postponing childbearing in childless cohabiting and single women aged 35–43 seeking fertility assessment and counseling. Hum Reprod. 2015;30(11):2563–74.

    Article  CAS  PubMed  Google Scholar 

  2. Cobo A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105(3):755–64. e8

    Article  PubMed  Google Scholar 

  3. Cobo A, García-Velasco JA. Why all women should freeze their egg. Curr Opin Obstet Gynecol. 2016;28(3):206–10.

    Article  PubMed  Google Scholar 

  4. Menken J, Trussell J, Larsen U. Age and infertility. Science. 1986;234(5775):413.

    Google Scholar 

  5. FJM B, et al. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline. BMC Med. 2016;14(1):151.

    Article  Google Scholar 

  6. Armstrong D. Effects of maternal age on oocyte developmental competence. Theriogenology. 2001;55(6):1303–22.

    Article  CAS  PubMed  Google Scholar 

  7. Allersma T, Farquhar C, Cantineau AE. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane Database Syst Rev. 2013;30(8):CD010550. doi: 10.1002/14651858.CD010550.pub2.

  8. Bosch E, Ezcurra D. Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients. Reprod Biol Endocrinol. 2011;9:82.

    Article  PubMed  PubMed Central  Google Scholar 

  9. van Loendersloot LL, et al. Individualized decision-making in IVF: calculating the chances of pregnancy. Hum Reprod. 2013;28(11):2972–80.

    Article  PubMed  Google Scholar 

  10. Wong JM, Forrest KA, Snabes SZ, et al. Efficacy of nafarelin in assisted reproductive technology: a meta-analysis. Hum Reprod Update. 2001;7(1):92–101.

    Article  CAS  PubMed  Google Scholar 

  11. Pacchiarotti A, et al. Ovarian stimulation protocol in IVF: an up-to-date review of the literature. Curr Pharm Biotechnol. 2016;17(4):303–15.

    Article  CAS  PubMed  Google Scholar 

  12. Stimpfel M, et al. Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patients. Int J Endocrinol. 2015;2015:385049.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Al-Inany HG, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4:CD001750.

    PubMed  Google Scholar 

  14. Olivennes F, et al. Multiple Dose International Study Group.; Cetrotide Single Dose International Study Group. Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences. Reprod Biomed Online. 2003;6(4):432–8.

    Article  CAS  PubMed  Google Scholar 

  15. Wilcox J, et al. Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril. 2005;84(1):108–17.

    Article  CAS  PubMed  Google Scholar 

  16. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14(5):640–9.

    Article  CAS  PubMed  Google Scholar 

  17. Krishna D, Dhoble S, Praneesh G, Rathore S, Upadhaya A, Rao K. Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial. J Hum Reprod Sci. 2016;9(3):164–72.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Popovic-Todorovic B, Loft A, Lindhard A, Bangsbøll S, Andersson AM, Andersen AN. A prospective study of predictive factors of ovarian response in ‘standard’ IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod. 2003;18(4):781–7.

    Article  CAS  PubMed  Google Scholar 

  19. Pouly JL, French CONSORT Study Group, et al. Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study. Reprod Biomed Online. 2015;31(3):347–55.

    Article  CAS  PubMed  Google Scholar 

  20. Garcia-Velasco JA, et al. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial. Fertil Steril. 2011;96(3):590–3. doi:10.1016/j.fertnstert.2011.06.022.

    Article  CAS  PubMed  Google Scholar 

  21. Banker M, Garcia-Velasco JA. Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic. J Hum Reprod Sci. 2015;8(1):13–7. doi:10.4103/0974-1208.153120.Review.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kwan I, Bhattacharya S, Kang A, Woolner A. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev. 2014;24(8):CD005289. doi: 10.1002/14651858.CD005289.pub3.

  23. Cakmak H, Rosen MP. Random-start ovarian stimulation in patients with cancer. Curr Opin Obstet Gynecol. 2015;27(3):215–21.

    Article  PubMed  Google Scholar 

  24. Requena A, et al. Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin α. Reprod Biomed Online. 2013;26(3):253–9.

    Article  CAS  PubMed  Google Scholar 

  25. Fatemi HM, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and “freeze-all” approach in GnRH antagonist protocol. Fertil Steril. 2014;101(4):1008–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IVI-Madrid, Rey Juan Carlos University, Avenida del Talgo 68, Aravaca, Madrid, 28023, Spain

    C. Iglesias M.D. & J. A. García-Velasco M.D.

Authors
  1. C. Iglesias M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. García-Velasco M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Iglesias M.D. .

Editor information

Editors and Affiliations

  1. Centre for Reproductive Medicine, UZ Brussel, Brussels, Belgium

    Dominic Stoop

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Iglesias, C., García-Velasco, J.A. (2018). Ovarian Stimulation Prior to Elective Oocyte Cryopreservation. In: Stoop, D. (eds) Preventing Age Related Fertility Loss. Springer, Cham. https://doi.org/10.1007/978-3-319-14857-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14857-1_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14856-4

  • Online ISBN: 978-3-319-14857-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation